The Trump administration has recently unveiled a draft framework aimed at expediting the approval process for biosimilar drugs, which are…
Trending
- Expanding clinical trials by allowing people to participate from home
- Study finds silicosis compensation costs set to continue rising in Victoria despite engineered stone ban
- McCormick ups tariff impact to $140M despite mitigation efforts
- Swedish study links temperature extremes to higher death risk in heart failure
- Clinical trial shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia
- What Gold Medalist Erin Jackson Wants You To Know About Eczema
- STAT+: FDA moves to ease path for biosimilars as Trump seeks to cut drug costs
- The Best Way to Open an English Muffin Will Blow Your Mind